News

Deal Announcements

Sadra Medical Closes $19M To Fund Development

Tuesday, October 24, 2006 9:00:00 AM PDT | VentureDeal Staff

CAMPBELL, CA --

Sadra Medical closed its Series B round and garnered $19 million more to continue development of aortic valve disease treatments.

Participating investors included Oakwood Medical Investors, Boston Scientific as well as Series A investors Pequot Ventures, Onset Ventures and SV Life Sciences Advisors.

The company is developing a percutaneous aortic valve replacement solution they call the "Sadra Lotus Valve."

Sadra Medical was founded in 2003 and previously received Series A funding of $9 million.

Email Page  Email Page | Print Page Print Page

Loading

Free Trial

Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?

Start your Free 14 Day Trial now – no obligation or credit card required.

Free 14 day trial. No Obligation. Click to Register.